The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Like most things in the body, too much or too little is a bad thing. So if you have no mTORC1, for example, in your muscles, you'd wither away and that would be a debilitating condition. In fact, for people with muscular dystrophy one of the things you want to do is figure out how to alter that pathway. But similarly, we know that overactivity is predisposing us to aging and, of course, certain diseases of aging like cancer.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.